| Code | 45365 | ||||||||||
| MA number | 09/0378/07-S | ||||||||||
| Product Form: | plv ifo 5x40 mg (liek.inj.skl.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Sandoz Pharmaceuticals d.d., Slovenia | ||||||||||
| Therapeutic Class: | 09 - ANTACIDA (VRÁTANE ANTIULCEROSNYCH LIEČIV) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 18.10.2007 |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Omeprazol Sandoz 40 mg prášok na infúzny roztok_12_2024.pdf
|
| SPC: |
SPC_Omeprazol Sandoz 40 mg prášok na infúzny roztok_12_2024.pdf
|
| Safety feature | Yes |
| Data update: | 30.05.2018 |
